Skip to content
DE

Shatavari

Clinical review pending

Shatavari is traditionally used for hormonal and reproductive complaints. Which effects have been studied, and where data on benefits and safety are missing.

Editorial draft. The medical source check is documented; final clinical sign-off is still pending.

Shatavari has a long history in Ayurvedic women’s medicine. Recent studies give reason to keep investigating certain extracts for menopausal symptoms and for supporting early milk production. The positive results are interesting, but they cannot be extended to every product or to a general “hormone balance.”

Shatavari as a rasayana: an Ayurvedic tonic for women

Shatavari is the root of Asparagus racemosus, a climbing plant common across the Indian subcontinent. In Ayurveda it is classed as a rasayana, one of the preparations traditionally used as tonics. That label describes cultural use; it is not a modern assessment of efficacy. Among other compounds, the root contains steroidal saponins, flavonoids and alkaloids. It is sold as root powder and as extracts of varying concentration. Source

Many products are marketed for menopause, breastfeeding and stress. Which claim is justified, however, depends on the specific complaint and the preparation that was studied. A traditional use and a positive study result answer different questions. Source

Steroidal saponins and the shatavarin series

The saponins that have been studied include the shatavarins, especially shatavarin IV. They are the focus of much laboratory work. The plant also contains other, chemically distinct groups of compounds; not every one of them is a flavonoid, and they do not all act the same way. Source · Source

One proposed explanation for hormone-related effects is that individual constituents interact with hormone receptors. Computer models can point to candidate compounds. What they do not yet show is which substances, once swallowed, reach human tissue in an effective concentration.

From Ayurvedic rasayana to a global supplement range

Its use to support women after childbirth and during breastfeeding is documented in ethnomedicine. International reviews and regional surveys describe these uses, but describing them does not automatically test their clinical benefit. Source · Source

The name, often translated as “she who has a hundred husbands,” reflects the traditional association with female vitality. Today a wide range of products and promises are drawn from that history. For a concrete decision, the more informative evidence comes from the newer controlled studies with a clearly named extract, a comparison group and a defined outcome. Source

Possible effects on estrogen receptors, cortisol and milk production

Research is pursuing several lines: possible hormone-like effects, changes in the stress response and support for milk production. These questions remain worth asking even though the mechanism is not yet fully understood. What matters is whether an effect seen in the lab also shows up as an improvement women can actually feel.

Three pathways with uneven evidence

A docking study modeled how shatavarins might fit female hormone receptors. In a rat experiment, a combination of fenugreek and shatavari reduced hot-flash-like responses after the ovaries were removed. The contribution of shatavari alone cannot be worked out from that combination. Another experiment examined inflammatory and vascular markers in rats with artificially induced preeclampsia. It provides no treatment recommendation for pregnant women. Source · Source · Source

For milk production, one proposed mechanism is an effect on prolactin. In buffaloes given shatavari, researchers observed more milk along with higher prolactin and cortisol levels. That is a hint from animal research; it shows neither a reduction in cortisol in humans nor a generally “balanced” stress axis. Source

The Cochrane review of agents that promote milk production included shatavari, but it rated the certainty of the available evidence as low to very low overall. The existence of a Cochrane assessment is therefore no seal of quality for the efficacy of any single herb. Source

Absorption and breakdown: why products are not interchangeable

How well individual shatavarins are absorbed, transformed and excreted in humans is still poorly described. A lab finding therefore cannot simply be converted into an effective capsule dose. Source

The milligram figure alone is not enough to compare two products, either. Root powder, water-based extracts and products standardized to particular constituents can differ markedly in composition at the same weight. A study result belongs, first of all, to the preparation that was tested.

How well the effects of shatavari are supported

For menopausal symptoms, there are several randomized trials with positive results. For milk production, there are older mixed findings and newer encouraging ones. Research on muscle and hormones is so far smaller and more focused on individual measurements.

The assessment below takes into account study design, size, duration and the practical significance of the results. Several small trials with different products do not yet add up to a reliable general dose or a statement about long-term safety.

Menopausal symptoms: several positive, product-specific studies

A multicenter study of 70 women reported improvements in several menopausal symptoms compared with placebo. Another trial randomized 80 perimenopausal women, tested 300 mg of an extract daily for 8 weeks and found benefits on symptom and stress questionnaires. Source · Source

A three-arm study of 135 women compared shatavari, shatavari plus ashwagandha, and placebo over 8 weeks. The combination did better on some endpoints; those results cannot be credited entirely to shatavari alone. The authors declared no funding but thanked the manufacturer for supplying the extracts. Source

A six-arm study looked at shatavari, ashwagandha and their combination over 24 weeks. It found improvements in menopause-related quality of life and in certain markers of vascular function and bone metabolism. Markers like these are not yet proof that heart attacks or fractures are prevented. Source

A further study of 60 women tested 100 mg of a proprietary extract daily for 8 weeks and also reported fewer symptoms. It was funded by the manufacturer, and both authors were employed there. Taken together, these are positive signals. But because the studies are small, product-specific and short, it remains open how lasting the effects are and whether they carry over to other products. Source

Milk production: encouraging results for the first days after birth

Older reviews describe a mixed and methodologically limited body of studies. In particular, the 2020 Cochrane review could not reliably establish long-term benefits for breastfeeding or for the infants. Source · Source · Source

Newer controlled studies add to this picture. In 78 women, more milk was pumped after a shatavari-containing bar than after a comparison bar. A 2025 study that enrolled 120 women also found more expressed milk and higher satisfaction after 72 hours; the efficacy analysis included the 113 women who completed the study. Both trials concern the very early period after birth. They do not yet tell us whether women go on to breastfeed exclusively for longer or whether their babies thrive better in the long run. Source · Source

If you are worried about your milk supply, lactation counseling is therefore the most sensible first step. A lactation consultant can check latching, milk transfer and treatable causes. Shatavari would at most be an add-on, discussed for your individual situation. LactMed

Muscle strength and training: first signals, mixed results

In a small study of 20 postmenopausal women, 1,000 mg daily for 6 weeks improved handgrip strength: by an average of 0.7 kg, compared with a decrease of 0.4 kg on placebo. Knee extensor strength and bone markers showed no corresponding benefit. Source

A later analysis of muscle samples from the same study described changes in protein patterns. It offers mechanistic insight, not independent confirmation of the effect on strength. Source

In another training study, 22 older and 17 younger women completed an 8-week program. On shatavari, the older participants were able to handle more load during training, but their muscle strength measured at the end was no better than on placebo. That raises an interesting question about resistance to fatigue, but it does not yet show a reliable extra gain in strength. A systematic review of supplements used alongside strength training rates the data as insufficient for concrete recommendations. Source · Source

Stress and hormones: specific measurements, not a general balance

“Adaptogen” is a traditional or pharmacological description, not a diagnosis of an individual need. Some shatavari studies measure subjective stress and find improvements. That does not mean the extract treats every form of stress or a specific disorder of cortisol regulation. Source · Source

A few newer studies also report changes in hormone levels such as estradiol and FSH. These values fluctuate during perimenopause and should not be equated with a rejuvenated ovarian reserve or higher fertility. Source

There is now controlled research on PCOS as well. In a study of 70 women, follicle count, endometrial thickness and perceived stress changed after 12 weeks. Ovarian volume and the hormones measured did not differ significantly from placebo. Benefits for ovulation, pregnancies and live births were not shown, and a thicker uterine lining is not an advantage in every situation. Early findings like these justify further research, but they are no substitute for individual PCOS or fertility treatment. Source

Standardized extract, whole root and why standardization matters

Many recent studies use defined root extracts. When comparing a study product with something on the shelf, the plant species, the part of the plant used, the extraction method and the standardization matter more than a high milligram figure on its own. A powder or tea is not automatically equivalent to an extract that was studied.

A traceable certificate of analysis can provide information on identity, constituents and contaminants. Independent quality testing, however, does not prove medical efficacy. LactMed explicitly points out that results from one preparation cannot simply be transferred to other products. LactMed

Harmful levels of heavy metals have been found in some Ayurvedic products. This warning concerns particular products and manufacturing practices; it does not mean contamination has been shown in every shatavari root. FDA warning

Regulatory status and what it means when choosing a product

In the United States, dietary supplements generally do not need FDA approval for efficacy and safety before they are sold. Manufacturers are responsible for safety and correct labeling; being marketed as a supplement is not the same as drug approval. Claims that a product treats or cures diseases are subject to different legal requirements. FDA

Traditional recognition in Ayurvedic medicine answers a different question from the clinical evaluation of a specific product. When choosing one, what counts is the exact composition, traceable testing and study data that fit your own situation.

Safety, side effects and drug interactions

In the small studies, the preparations tested were mostly well tolerated. That is reassuring for those specific uses and time frames. It says only a limited amount about rare side effects, longer use or combination with several medications.

What the menopause and lactation RCTs recorded

The three-arm menopause study reported few, mild events overall: nausea on shatavari, for example, and loose stools and dizziness, among others, on the combination; complaints also occurred on placebo. Source

In the 24-week comparison study, three women taking 500 mg of shatavari reported mild gastrointestinal complaints. No one dropped out because of them. Other short studies likewise found no serious safety signals. None of this allows a blanket ranking of the “most common” side effects across all shatavari products. Source · Source · Source

The newer early breastfeeding studies reported no adverse events. Their short duration, however, limits what can be said about longer-term safety for mother and child. Source · Source

Which interactions are possible

Well-documented studies of interactions in humans are largely missing. Three questions still deserve attention:

  • Hormone-active medications: The proposed hormone-like effect is a reason to discuss shatavari with your care team beforehand if you take tamoxifen, aromatase inhibitors or other hormone treatments. This does not mean a clinical interaction has been shown. Source
  • Lithium and diuretics: A rat experiment found a diuretic effect at a very high extract dose. Whether typical products act similarly in humans remains open. With lithium, any additional product should as a rule be checked by a doctor or pharmacist, because the treatment is finely balanced. This does not establish a shatavari-specific clinical interaction. Source
  • Diabetes medications and other drugs: Preclinical metabolic effects are not a reliable guide for adjusting doses in humans. So do not change prescribed medications on the strength of a supplement’s promise.

For an informed conversation, a complete list of all medications and supplements helps more than a blanket “adaptogen” label.

Extra caution: pregnancy, breastfeeding and organ function

Pregnancy: Safe use of concentrated preparations has not been adequately established. Do not use them during pregnancy or when trying to conceive without consulting a professional. Positive animal data from a preeclampsia model cannot answer this safety question.

Breastfeeding: Here there is a concrete research tradition and some first positive clinical results. Even so, reliable data on how much of the active compounds reach breast milk, and on long-term safety, are missing. A lactation consultant and your medical team can weigh the benefits and the open questions together. LactMed

Hormone-sensitive conditions, liver or kidney disease: The existing trials do not adequately cover these situations. With hormone-sensitive cancer, the decision belongs with the oncology team. If you have had a reaction to shatavari, avoid it; if you have an asparagus allergy, have an allergist clarify whether you are likely to tolerate it before you try it.

When shatavari is not suitable

Discuss taking it beforehand if you are pregnant, planning a pregnancy, breastfeeding, have a relevant organ condition or take medication regularly. Hormone-modulating treatments and lithium deserve particular attention. These are different situations calling for caution, not equally well-supported absolute contraindications.

Children should not be given such products without a pediatrician’s indication. Anyone with a known allergy to shatavari should not take it. And irregular bleeding, suspected PCOS or difficulty conceiving should not be left uninvestigated while you run a long self-experiment with supplements.

Shatavari vs. ashwagandha for women’s health

The two plants are not chemically or clinically interchangeable. Shatavari contains steroidal saponins, among other compounds; in ashwagandha, withanolides take center stage. For shatavari, many of the newer studies concern menopausal symptoms and breastfeeding. For certain ashwagandha preparations, the US research institute NCCIH sees signs of benefit for stress and sleep problems; the data on anxiety are less clear. NCCIH

The 2025 head-to-head comparison found improvements in menopause-related symptoms with both plants. Ashwagandha did better on several measures; no special superiority of shatavari for all women can be drawn from that. The particular extracts and doses belong to that specific study. Source

The safety questions differ, too. With ashwagandha, points to watch include rare liver injury, interactions with thyroid medication and restrictions during pregnancy and breastfeeding. Less safety data on shatavari does not automatically make it the safer alternative. NCCIH

In practice, start by being clear about the goal: is it hot flashes, sleep or milk supply? Then you can discuss which established and complementary options make sense for that situation.

Which tests can actually be useful

A routine hormone panel before taking shatavari is not necessary. In otherwise healthy women aged 45 and over with typical menopausal symptoms, the assessment is usually based on symptoms and the menstrual cycle. NICE does not recommend routine estradiol or AMH tests for this; FSH is an option only in selected situations. NICE

A morning cortisol reading does not measure a personal “adaptogen need,” either. If a disorder of cortisol is suspected, targeted medical testing is needed; a single random blood value is not enough to investigate Cushing’s syndrome, for example. Endocrine Society

Other tests depend on the symptoms. If there are signs of anemia or iron deficiency, appropriate testing can make sense. With breastfeeding problems, what counts first is the observed milk transfer and how the baby is developing. For tracking a subjective change in symptoms, a simple symptom diary is often more helpful than an untargeted series of lab values.

When hormonal complaints should be checked by a doctor

If hot flashes, sleep problems or cycle-related complaints seriously affect daily life, a gynecological consultation is worthwhile. There, established treatment options, personal risks and the wish for complementary remedies can be discussed together.

Difficulty conceiving, unusual bleeding or persistent complaints after childbirth need targeted investigation. Shatavari may be an option under research; it should not delay the search for a treatable cause.

Frequently asked questions

What is shatavari?

Shatavari is the root of Asparagus racemosus, a plant traditionally used in Ayurveda. Among other compounds it contains saponins, and today it is sold as a powder or extract. Traditional women’s medicine, lab findings and clinical trials each provide a different kind of knowledge. Source

Does shatavari actually help with menopausal symptoms?

Several small studies report fewer symptoms with certain extracts. That is a reasonable basis for further research and a possible topic to raise with your doctor. The long-term effect and whether the results carry over to other products are still open. A supplement does not automatically replace a proven treatment. Source · Source

What shatavari dose was used in studies?

Doses and preparations vary considerably. One study used 300 mg daily for 8 weeks. Another trial tested 250 or 500 mg over 24 weeks. The muscle study, with 1,000 mg over 6 weeks, addressed a different question. These figures are study conditions, not a general dosing recommendation. Source · Source · Source

What are the side effects of shatavari?

Individual studies reported nausea and other mild gastrointestinal complaints, among others. The small samples do not allow any firm statement about how often rare or long-term problems occur. If new symptoms appear after you start taking it, stop the product and have them assessed by a medical professional. Source · Source

Is shatavari FDA-approved?

In the United States, dietary supplements are generally not approved for efficacy before sale the way medicines are. A reference to FDA rules or to manufacturing under quality standards is therefore no proof that shatavari works. FDA

How does shatavari compare with ashwagandha?

Shatavari is studied mainly for menopausal symptoms and breastfeeding. For ashwagandha, there are signs that certain preparations help with stress and sleep problems. This does not produce a general ranking; the goal, the product and your personal risks all have to fit together. NCCIH

Who should avoid shatavari?

If you have a known shatavari allergy, avoid the product. During pregnancy, when trying to conceive, with hormone-sensitive conditions, relevant liver or kidney problems, and while taking medication, talk to a professional first. During breastfeeding, the limited safety data and your specific breastfeeding situation should be taken into account.

Which blood tests should I have before trying shatavari?

There is no generally recommended shatavari lab panel. Whether blood tests are needed depends on your symptoms and any possible underlying conditions. Typical menopausal symptoms from age 45 can usually be assessed without hormone measurements; cortisol is not a test for a need for adaptogens. NICE

Sources and further reading

Origin and editorial review status

Editorially adapted from the Superpower article and revised on the basis of the documented medical source check. The check covers publication identity, accessible abstracts, selectively read full-text sections and guidelines. Some full texts and detailed questions remain only partly accessible. Final clinical sign-off is still pending; the draft remains excluded from indexing.